Annie Kennedy

Metabolic Enzyme DLST Promotes Tumor Aggression and Reveals a Vulnerability to OXPHOS Inhibition in High-Risk Neuroblastoma

A. Look, T. Tao, G. Qing, 2021, Cancer Research.

Circulating tumor DNA reveals mechanisms of lorlatinib resistance in patients with relapsed/refractory ALK-driven neuroblastoma

J. Maris, Y. Mossé, M. Lemmon, 2023, Nature communications.